Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Dis Esophagus ; 24(3): 131-7, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20946132

RESUMEN

Foreign bodies should not be allowed to remain in the esophagus beyond 24 hours after presentation. However, some patients with esophageal foreign body ingestion do not come to the hospital immediately and may delay medical intervention from the time of ingestion. The aim of this study was to investigate the outcomes of adults with suspected esophageal foreign body ingestion according to the time of ingestion and types of foreign bodies. A total of 326 adult patients (151 men and 175 women) were analyzed, and divided into two groups according to the time period: within or beyond 24 hours from ingestion to endoscopic intervention. A total of 172 patients (52.7%) were found to have ingested foreign bodies; 73.5% were removed smoothly, 10.3% were treated by push technique and 16.0% with failed retrieval received alternative treatments. A higher proportion of patients in the beyond-24 hours group suffered from odynophagia (25.9 vs. 12.9%, P < 0.05). Negative identification of esophageal foreign bodies was more frequent in the beyond-24 hours group (67 vs. 40.2%, P < 0.05), but these patients showed higher proportions of esophageal ulcers (21.1 vs. 7.2%, P < 0.05). The beyond-24 hours group also showed a significantly higher rate of foreign bodies in the lower esophagus (40.0 vs. 15.3%, P < 0.05). Patients with esophageal food bolus impaction had significant delayed endoscopic intervention, longer therapeutic endoscopic time, higher proportions of esophageal cancer, stricture and fewer complications. Endoscopic intervention within 24 hours from the time of ingestion should be considered early in adults, because delaying intervention may produce more symptomatic esophageal ulcerations with odynophagia.


Asunto(s)
Esófago , Cuerpos Extraños/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Esofagoscopía , Femenino , Alimentos , Cuerpos Extraños/complicaciones , Cuerpos Extraños/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
2.
Dis Esophagus ; 23(2): 122-7, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19473206

RESUMEN

Carcinosarcoma of the esophagus is a rare neoplasm with both carcinomatous and sarcomatous components. This study aimed to investigate its clinicopathologic features and endoscopic characteristics. The data of patients diagnosed to have esophageal carcinosarcoma pathologically in the past 30 years (January 1976-December 2007) were reviewed. Of 3318 cases of esophageal malignancy, 12 were diagnosed as esophageal carcinosarcoma, with an incidence of 0.36%. All of the cases were male with a mean age of 62.3 years. Of the 12 tumors, 8 were polypoid type, and 4 were ulcerative type. In the endoscopic ultrasonography examination, the tumors show heterogeneous hypoechoic lesions with irregular outer margins and internal multicystic components. Four patients (33.3%) had previous head and neck squamous cell carcinoma that occurred metachronously. This is the first report about the characteristics of esophageal carcinosarcoma under endoscopic ultrasonography examination. The relationship between esophageal carcinosarcomas and head and neck cancer needs further investigation.


Asunto(s)
Carcinosarcoma/epidemiología , Neoplasias Esofágicas/epidemiología , Factores de Edad , Anciano , Consumo de Bebidas Alcohólicas/epidemiología , Areca , Carcinoma de Células Escamosas/epidemiología , Carcinosarcoma/secundario , Endoscopía del Sistema Digestivo , Endosonografía , Estudios de Seguimiento , Neoplasias de Cabeza y Cuello/epidemiología , Humanos , Incidencia , Metástasis Linfática , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Primarias Secundarias/epidemiología , Pólipos/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Fumar/epidemiología , Tasa de Supervivencia , Taiwán/epidemiología , Úlcera/epidemiología
3.
J Hand Surg Eur Vol ; 42(6): 633-639, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27913807

RESUMEN

We have used laser Doppler imaging to monitor the microcirculation of replanted digits during the post-operative period in 103 patients who underwent either replantation after traumatic amputation or toe-to-finger reconstruction. The blood flow (perfusion unit) in each revascularized digit was compared with that of an unaffected digit. The perfusion index was defined as the perfusion value of a revascularized digit divided by the perfusion value of the neighbouring normal digit. The ideal threshold value of the perfusion index (0.397) was calculated by determining the receiver operating characteristic curve with optimal sensitivity and specificity. The corresponding Youden's index was 0.828. We believe that by establishing a threshold, that laser Doppler imaging should provide a reliable and objective assessment for the development of perfusion compromise in revascularized digits. LEVEL OF EVIDENCE: III.


Asunto(s)
Amputación Traumática/diagnóstico por imagen , Traumatismos de los Dedos/diagnóstico por imagen , Flujometría por Láser-Doppler , Microcirculación/fisiología , Flujo Sanguíneo Regional/fisiología , Reimplantación , Adolescente , Adulto , Amputación Traumática/fisiopatología , Amputación Traumática/cirugía , Traumatismos de los Dedos/fisiopatología , Traumatismos de los Dedos/cirugía , Humanos , Masculino , Microcirugia , Persona de Mediana Edad , Reproducibilidad de los Resultados , Estudios Retrospectivos , Sensibilidad y Especificidad , Procedimientos Quirúrgicos Vasculares , Adulto Joven
4.
Eur Rev Med Pharmacol Sci ; 21(7): 1551-1558, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28429351

RESUMEN

OBJECTIVE: Myocardial apoptosis is an important pathologic basis of ischemia-reperfusion injury (I/R). Transforming growth factor ß1 (TGFß1) participates in the regulation of oxidative damage and apoptosis. TGFß1 is upregulated in the repair process of I/R injury. It is speculated that TGFß1 over-expression is involved in the endogenous protective mechanism of I/R injury. This study explores the significance of TGFß1 in myocardial cell apoptosis after I/R. MATERIALS AND METHODS: Rat myocardial I/R injury model was established. Left ventricular ejection fraction (LVEF) and Left ventricular fractional shortening (LVFS) were detected by ultrasonic cardiogram. TGFß1 expression in the myocardium was tested. H9C2 cells were cultured under ischemic hypoxic condition for 6 h, and then were treated by reoxygenation for 6 h to simulate I/R model. H9C2 cells were divided into three groups, including I/R+pIRES2-Blank, I/R+pIRES2 TGFß1, and I/R+pIRES2-TGFß1+LY364947. TGFß1 mRNA and protein levels were evaluated. Cell apoptosis and reactive oxygen species (ROS) were determined by flow cytometry. RESULTS: LVEF and LVFS significantly decreased in I/R group compared with Sham group. TGFß1 mRNA and protein expressions in myocardium from I/R group up-regulated than the control. I/R treatment markedly elevated TGFß1 mRNA and protein levels, increased ROS content, and enhanced cell apoptosis in H9C2 cells. Over-expression of TGFß1 significantly weakened ROS production and apoptosis in H9C2 cells after I/R. TGFß receptor inhibitor LY364947 restrained ROS production and apoptosis attenuation in H9C2 cells treated by TGFß. CONCLUSIONS: TGFß1 alleviates myocardial cell apoptosis after I/R. Blocking TGFß1 attenuates the protective effect of TGFß1 on I/R injury.


Asunto(s)
Apoptosis/efectos de los fármacos , Daño por Reperfusión Miocárdica , Factor de Crecimiento Transformador beta1/metabolismo , Animales , Miocardio/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo
5.
Phys Rev Lett ; 67(4): 473-476, 1991 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-10044903
12.
Br J Cancer ; 97(10): 1409-15, 2007 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-18000500

RESUMEN

Id protein family consists of four members namely Id-1 to Id-4. Different from other basic helix-loop-helix transcription factors, they lack the DNA binding domain. Id proteins have been shown to be dysregulated in many different cancer types and their prognostic value has also been demonstrated. Recently, Id-1 has been shown to be upregulated in oesophageal squamous cell carcinoma (ESCC). However, the prognostic implications of Id proteins in ESCC have not been reported. We examined the expression of the Id proteins in ESCC cell lines and clinical ESCC specimens and found that Id protein expressions were dysregulated in both the ESCC cell lines and specimens. By correlating the expression levels of Id proteins and the clinicopathological data of our patient cohort, we found that M1 stage tumours had significantly higher nuclear Id-1 expression (P=0.012) while high nuclear Id-1 expression could predict development of distant metastasis within 1 year of oesophagectomy (P=0.005). In addition, high levels of Id-2 expression in both cytoplasmic and nuclear regions predicted longer patient survival (P=0.041). Multivariate analysis showed that high-level expression of Id-2 in both cytoplasmic and nuclear regions and lower level of nuclear Id-1 expression were independent favourable predictors of survival in our ESCC patients. Our results suggest that Id-1 may promote distant metastasis in ESCC, and both Id-1 and Id-2 may be used for prognostication for ESCC patients.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/secundario , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/secundario , Proteína 1 Inhibidora de la Diferenciación/biosíntesis , Proteína 2 Inhibidora de la Diferenciación/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/metabolismo , Línea Celular Tumoral , Estudios de Cohortes , Células Epiteliales/patología , Neoplasias Esofágicas/metabolismo , Esófago/patología , Femenino , Humanos , Inmunohistoquímica , Proteínas Inhibidoras de la Diferenciación/biosíntesis , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Análisis Multivariante , Valor Predictivo de las Pruebas , Pronóstico , Tasa de Supervivencia
13.
Int J Clin Pract ; 60(2): 160-6, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16451287

RESUMEN

The aim of the study was to evaluate the usefulness of sequential organ failure assessment (SOFA) and acute physiology, age, chronic health evaluation III (APACHE III) scoring systems obtained on the first day of intensive care unit (ICU) admission in predicting hospital mortality in critically ill cirrhotic patients. The study enrolled 102 cirrhotic patients consecutively admitted to ICU during a 1-year period. Twenty-five demographic, clinical and laboratory variables were analysed as predicators of survival. Information considered necessary to calculate the Child-Pugh, SOFA and APACHE III scores on the first day of ICU admission was also gathered. Overall hospital mortality was 68.6%. Multiple logistic regression analysis revealed that mean arterial pressure, SOFA and APACHE III scores were significantly related to prognosis. Goodness-of-fit was good for the SOFA and APACHE III models. Both predictive models displayed a similar degree of the best Youden index (0.68) and overall correctness (84%) of prediction. The SOFA and APACHE III models displayed good areas under the receiver-operating characteristic curve (0.917 +/- 0.028 and 0.912 +/- 0.029, respectively). Finally, a strong and significant positive correlation exists between SOFA and APACHE III scores for individual patients (r(2) = 0.628, p < 0.001). This investigation confirms the grave prognosis for cirrhotic patients admitted to ICU. Both SOFA and APACHE III scores are excellent tools to predict the hospital mortality in critically ill cirrhotic patients. The overall predictive accuracy of SOFA and APACHE III is superior to that of Child-Pugh system. The role of these scoring systems in describing the dynamic aspects of clinical courses and allocating ICU resources needs to be clarified.


Asunto(s)
APACHE , Cirrosis Hepática/mortalidad , Insuficiencia Multiorgánica/mortalidad , Cuidados Críticos , Enfermedad Crítica , Métodos Epidemiológicos , Femenino , Mortalidad Hospitalaria , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Prospectivos
14.
Int J Clin Pract ; 59(11): 1289-94, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16236082

RESUMEN

Hepatitis B virus (HBV) infection is the most prevalent cause of fulminant hepatic failure (FHF) in the Far East. HBV-associated FHF is characterised by rapidly progressive end organ dysfunction/failure and a very poor prognosis. To investigate how molecular adsorbent recirculating system (MARS) treatment impacts multiple organ system function in HBV-associated FHF. Ten consecutive patients were treated with MARS in a period of 12 months. Clinical, biochemical and haemodynamic parameters were assessed before and after MARS. Various disease severity scoring systems including model for end-stage liver disease, APACHE II, APACHE III, sequential organ failure assessment and organ system failure scores were also assessed. There were significant improvements in hepatic encephalopathy grading (p < 0.001), mean arterial pressure (p < 0.001), plasma renin activity (p = 0.027), bilirubin (p < 0.001), ammonia (p = 0.001) and creatinine levels (p < 0.001). There were also significant improvements in all the scoring systems evaluated. Meanwhile, platelet count was significantly decreased (p < 0.001). One patient was successfully bridged to liver transplantation. Three patients were alive at 3 months of follow-up. MARS can improve multiple organ functions in HBV-associated FHF. On the basis of these findings, randomised controlled studies are indicated and justified.


Asunto(s)
Hemodiafiltración/métodos , Hepatitis B/complicaciones , Fallo Hepático Agudo/terapia , Adulto , Anciano , Femenino , Hemodinámica , Humanos , Fallo Hepático Agudo/virología , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
15.
Phys Rev C Nucl Phys ; 46(5): 2042-2046, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9968324
17.
18.
Phys Rev C Nucl Phys ; 33(6): 2159-2162, 1986 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9953398
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA